ACCUEIL N°1 EN - NE PAS SUPPRIMER !

News

Partners since 2019, Institut Curie and Biomunex announce a new stage in their strategic research collaboration. Already co-inventor and 50% co-owner of this approach, Biomunex has signed an exclusive licensing agreement with Institut Curie for the clinical development of a new class of antibodies, capable of specifically targeting, engaging and redirecting MAIT cells to destroy cancer cells. A further step towards new, safer and more effective cutting-edge immunotherapies for the benefit of patients.

06/20/2023 - 18:40

Under the effects of climate change, weather events are becoming more frequent and intense in terms of loss experience and damage costs. Lightweight structures such as houses and houses and roads, built on very plastic clay soils and sensitive to the shrinkage and swelling phenomena, suffer more degradations due to drought.
The Cerema, Institut Carnot Institute Clim'adapt, works and mobilizes those concerned to develop new remedial solutions to reduce the vulnerability of buildings exposed to the RGA and its resilience to climate change.

Neuroscientists and neurosurgeons from EPFL/CHUV/UNIL and CEA/FDD Clinatec/CHUGA/UGA report in the journal Nature that they have re-established the communication between the brain and spinal cord with a wireless digital bridge, allowing a paralyzed person to walk again naturally.

06/20/2023 - 18:24

AVATAR MEDICAL helps surgeons better prepare their procedures through the use of virtual reality (VR) representations of their patients. These patient avatars are generated instantly from CT scan or MRI images with an underlying proprietary technology based on four years of research in human-data interaction and machine learning conducted at Institut Curie and Institut Pasteur (both Carnot Institute)

For the first time worldwide, an artificial intelligence (AI) tool is clinically validated for breast cancer diagnosis. Institut Curie and Ibex Medical Analytics, a pioneer in AI-based cancer diagnosis, demonstrate the performance, reliability and clinical application of an AI algorithm for breast biopsy diagnosis. These results were just published in the journal npj breast cancer.

Valeo and the Carnot Institute CEA LETI signed an agreement to collaborate on the next generations of power electronics, which are at the heart of the challenges facing tomorrow's electric mobility.